Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ruohong Yan
Structure-Guided Development of Dual Inhibitors of EGFR and JNK to Treat GBM and NSCLC
Biophysical Journal
Biophysics
Related publications
Discovery of Novel Dual Inhibitors of Receptor Tyrosine Kinases EGFR and IGF-1R
Journal of Enzyme Inhibition and Medicinal Chemistry
Medicine
Drug Discovery
Pharmacology
EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors
Clinical Cancer Research
Cancer Research
Oncology
Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Fragment-Based and Structure-Guided Discovery and Optimization of Rho Kinase Inhibitors
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Covalent JNK Inhibitors?
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
P1.13-23 TP53 Mutations as Mechanisms of Primary and Acquired Resistance to Tyrosine Kinase Inhibitors in Patients With EGFR-Mutated NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.13-24 EGFR-KDD Is Rare and Demonstrates Variable Anti-Tumor Response to Tyrosine Kinase Inhibitors in East Asian NSCLC Population
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.13-27 Development, Internal Validation, and Calibration of a Risk Score to Predict Survival in Patients With EGFR Mutant NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Shikonin Sensitizes Wild‑type EGFR NSCLC Cells to Erlotinib and Gefitinib Therapy
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine